201 related articles for article (PubMed ID: 26113424)
1. A venous thromboembolism risk assessment model for patients with Cushing's syndrome.
Zilio M; Mazzai L; Sartori MT; Barbot M; Ceccato F; Daidone V; Casonato A; Saggiorato G; Noventa F; Trementino L; Prandoni P; Boscaro M; Arnaldi G; Scaroni C
Endocrine; 2016 May; 52(2):322-32. PubMed ID: 26113424
[TBL] [Abstract][Full Text] [Related]
2. Changes in coagulation indexes and occurrence of venous thromboembolism in patients with Cushing's syndrome: results from a prospective study before and after surgery.
Manetti L; Bogazzi F; Giovannetti C; Raffaelli V; Genovesi M; Pellegrini G; Ruocco L; Iannelli A; Martino E
Eur J Endocrinol; 2010 Nov; 163(5):783-91. PubMed ID: 20696792
[TBL] [Abstract][Full Text] [Related]
3. The thrombotic risk in Cushing's syndrome-questions, answers, and the algorithm to consider in its assessment: part I-thrombotic risk not related to surgery.
Bryk-Wiązania AH; Minasyan M; Świątkowska-Stodulska R; Undas A; Hubalewska-Dydejczyk A; Webb SM; Valassi E; Gilis-Januszewska A
Front Endocrinol (Lausanne); 2024; 15():1350010. PubMed ID: 38529392
[TBL] [Abstract][Full Text] [Related]
4. High prevalence of venous thrombotic events in Cushing's syndrome: data from ERCUSYN and details in relation to surgery.
Isand K; Feelders R; Brue T; Toth M; Deutschbein T; Reincke M; Kršek M; Santos A; Demtröder F; Chabre O; Strasburger CJ; Aulinas Maso A; Volke V; Pereira AM; Lohmann R; Gich Saladich I; ; Webb SM; Wass J; Valassi E
Eur J Endocrinol; 2024 Jan; 190(1):75-85. PubMed ID: 38146835
[TBL] [Abstract][Full Text] [Related]
5. Hypercoagulability in Cushing's syndrome: incidence, pathogenesis and need for thromboprophylaxis protocols.
Feelders RA; Nieman LK
Pituitary; 2022 Oct; 25(5):746-749. PubMed ID: 35881275
[TBL] [Abstract][Full Text] [Related]
6. Incidence of venous thromboembolism in patients with Cushing's syndrome: a multicenter cohort study.
Stuijver DJ; van Zaane B; Feelders RA; Debeij J; Cannegieter SC; Hermus AR; van den Berg G; Pereira AM; de Herder WW; Wagenmakers MA; Kerstens MN; Zelissen PM; Fliers E; Schaper N; Drent ML; Dekkers OM; Gerdes VE
J Clin Endocrinol Metab; 2011 Nov; 96(11):3525-32. PubMed ID: 21880802
[TBL] [Abstract][Full Text] [Related]
7. Venous thromboembolism in patients with Cushing's syndrome: need of a careful investigation of the prothrombotic risk profile.
Koutroumpi S; Daidone V; Sartori MT; Cattini MG; Albiger NM; Occhi G; Ferasin S; Frigo A; Mantero F; Casonato A; Scaroni C
Pituitary; 2013 Jun; 16(2):175-81. PubMed ID: 22585010
[TBL] [Abstract][Full Text] [Related]
8. Hypercoagulability in Cushing's syndrome: prevalence, pathogenesis and treatment.
van der Pas R; Leebeek FW; Hofland LJ; de Herder WW; Feelders RA
Clin Endocrinol (Oxf); 2013 Apr; 78(4):481-8. PubMed ID: 23134530
[TBL] [Abstract][Full Text] [Related]
9. Venous Thrombosis Risk after Cast Immobilization of the Lower Extremity: Derivation and Validation of a Clinical Prediction Score, L-TRiP(cast), in Three Population-Based Case-Control Studies.
Nemeth B; van Adrichem RA; van Hylckama Vlieg A; Bucciarelli P; Martinelli I; Baglin T; Rosendaal FR; le Cessie S; Cannegieter SC
PLoS Med; 2015 Nov; 12(11):e1001899; discussion e1001899. PubMed ID: 26554832
[TBL] [Abstract][Full Text] [Related]
10. Current clinical practice for thromboprophylaxis management in patients with Cushing's syndrome across reference centers of the European Reference Network on Rare Endocrine Conditions (Endo-ERN).
van Haalen FM; Kaya M; Pelsma ICM; Dekkers OM; Biermasz NR; Cannegieter SC; Huisman MV; van Vlijmen BJM; Feelders RA; Klok FA; Pereira AM;
Orphanet J Rare Dis; 2022 May; 17(1):178. PubMed ID: 35505430
[TBL] [Abstract][Full Text] [Related]
11. Incidence, outcome and risk stratification tools for venous thromboembolism in advanced pancreatic cancer - A retrospective cohort study.
Kruger S; Haas M; Burkl C; Goehring P; Kleespies A; Roeder F; Gallmeier E; Ormanns S; Westphalen CB; Heinemann V; Rank A; Boeck S
Thromb Res; 2017 Sep; 157():9-15. PubMed ID: 28675831
[TBL] [Abstract][Full Text] [Related]
12. Prediction of postdischarge venous thromboembolism using a risk assessment model.
Iannuzzi JC; Young KC; Kim MJ; Gillespie DL; Monson JR; Fleming FJ
J Vasc Surg; 2013 Oct; 58(4):1014-20.e1. PubMed ID: 23683384
[TBL] [Abstract][Full Text] [Related]
13. CUSHING'S SYNDROME, A RISK FACTOR FOR VENOUS THROMBOEMBOLISM IS A CANDIDATE FOR GUIDELINES.
Koraćević G; Stojanović M; Petrović S; Simić D; Sakač D; Vlajković M; Stevic M; Kocić M; Đorđević M; Koraćević M
Acta Endocrinol (Buchar); 2020; 16(2):123-128. PubMed ID: 33029226
[TBL] [Abstract][Full Text] [Related]
14. Clinical factors associated with venous thromboembolism risk in patients undergoing craniotomy.
Kimmell KT; Jahromi BS
J Neurosurg; 2015 May; 122(5):1004-11. PubMed ID: 25495743
[TBL] [Abstract][Full Text] [Related]
15. Hypercoagulability and other risk factors in trauma intensive care unit patients with venous thromboembolism.
Van Haren RM; Valle EJ; Thorson CM; Jouria JM; Busko AM; Guarch GA; Namias N; Livingstone AS; Proctor KG
J Trauma Acute Care Surg; 2014 Feb; 76(2):443-9. PubMed ID: 24398771
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of risk factors and assessment models for predicting venous thromboembolism in lung cancer patients.
Rupa-Matysek J; Lembicz M; Rogowska EK; Gil L; Komarnicki M; Batura-Gabryel H
Med Oncol; 2018 Apr; 35(5):63. PubMed ID: 29616356
[TBL] [Abstract][Full Text] [Related]
17. Time to Event Analysis for the Development of Venous Thromboembolism After Spinal Fusion ≥ 5 Levels.
McClendon J; Smith TR; O'Shaughnessy BA; Sugrue PA; Thompson SE; Koski TR
World Neurosurg; 2015 Sep; 84(3):826-33. PubMed ID: 25871780
[TBL] [Abstract][Full Text] [Related]
18. Caprini venous thromboembolism risk assessment permits selection for postdischarge prophylactic anticoagulation in patients with resectable lung cancer.
Hachey KJ; Hewes PD; Porter LP; Ridyard DG; Rosenkranz P; McAneny D; Fernando HC; Litle VR
J Thorac Cardiovasc Surg; 2016 Jan; 151(1):37-44.e1. PubMed ID: 26386868
[TBL] [Abstract][Full Text] [Related]
19. Hypercoagulability in Cushing's syndrome: From arterial to venous disease.
St-Jean M; Lim DST; Langlois F
Best Pract Res Clin Endocrinol Metab; 2021 Mar; 35(2):101496. PubMed ID: 33795197
[TBL] [Abstract][Full Text] [Related]
20. ONKOTEV Score as a Predictive Tool for Thromboembolic Events in Pancreatic Cancer-A Retrospective Analysis.
Godinho J; Casa-Nova M; Moreira-Pinto J; Simões P; Paralta Branco F; Leal-Costa L; Faria A; Lopes F; Teixeira JA; Passos-Coelho JL
Oncologist; 2020 Feb; 25(2):e284-e290. PubMed ID: 32043787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
